Literature DB >> 22954902

24-hour profiles of circulating ghrelin and peptide YY are inversely associated in normal weight premenopausal women.

Brenna R Hill1, Mary Jane De Souza, David A Wagstaff, Rino Sato, Nancy I Williams.   

Abstract

Peptide YY (PYY) and ghrelin (GHR) may modulate one another's actions within the hypothalamus. Peripheral infusion of PYY in humans acutely suppresses circulating concentrations of GHR. Whether an association between PYY and GHR exists in the peripheral circulation of humans over 24h is unknown. The purpose of this study was to determine if circulating concentrations of PYY and GHR were significantly associated over 24h in humans. Participants (n=13) were normal weight, moderately active, women ages 18-24 yr. Blood samples were obtained q10 min for 24 h and assayed using RIA for total PYY and total GHR hourly from 0800 to 1000 h and 2000 to 0800 h and q20 min from 1000 to 2000 h. Dietary intake during the 24 h procedure was comprised of 55% carbohydrates, 30% fat, and 15% protein (three meals and a snack). Statistical analyses included linear mixed-effects modeling to test whether PYY predicted GHR concentrations over 24h. Participants weighed 57.0±1.5 kg and had 26.1±1.5% body fat (15.0±1.1 kg), 42.1±1.1 kg fat free mass, a BMI of 21.3±0.5 kg/m(2) and RMR of 1072±28 kcal/24 h. Visually, PYY and GHR exhibited an inverse association over nearly the entire 24h period. Statistically, circulating concentrations of 24 h PYY predicted 24 h GHR (ghrelin=1860.51-2.14*PYY; p=0.04). Circulating concentrations of PYY are inversely associated with GHR over 24 h. These data provide evidence that PYY may contribute to the modulation of the secretion of GHR in normal weight, premenopausal women over a 24 h period and supports similar inferences from experimental studies in animals and humans. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22954902      PMCID: PMC3496067          DOI: 10.1016/j.peptides.2012.08.017

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  16 in total

1.  Ghrelin stimulates gastric acid secretion and motility in rats.

Authors:  Y Masuda; T Tanaka; N Inomata; N Ohnuma; S Tanaka; Z Itoh; H Hosoda; M Kojima; K Kangawa
Journal:  Biochem Biophys Res Commun       Date:  2000-10-05       Impact factor: 3.575

2.  Ghrelin promotes slow-wave sleep in humans.

Authors:  J C Weikel; A Wichniak; M Ising; H Brunner; E Friess; K Held; S Mathias; D A Schmid; M Uhr; A Steiger
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-10-15       Impact factor: 4.310

3.  Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite.

Authors:  Karine Spiegel; Esra Tasali; Plamen Penev; Eve Van Cauter
Journal:  Ann Intern Med       Date:  2004-12-07       Impact factor: 25.391

4.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

5.  Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.

Authors:  Thomas Riediger; Christine Bothe; Csilla Becskei; Thomas A Lutz
Journal:  Neuroendocrinology       Date:  2004-07-15       Impact factor: 4.914

6.  Peptide YY inhibits meal-stimulated pancreatic and gastric secretion.

Authors:  T N Pappas; H T Debas; Y Goto; I L Taylor
Journal:  Am J Physiol       Date:  1985-01

7.  Characterization of blood-brain barrier permeability to PYY3-36 in the mouse.

Authors:  Naoko Nonaka; Seiji Shioda; Michael L Niehoff; William A Banks
Journal:  J Pharmacol Exp Ther       Date:  2003-05-15       Impact factor: 4.030

8.  Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women.

Authors:  H J Leidy; J K Gardner; B R Frye; M L Snook; M K Schuchert; E L Richard; N I Williams
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

9.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

Review 10.  Regulation of ghrelin secretion and action.

Authors:  Jesus P Camiña; Marcos C Carreira; Dragan Micic; Manuel Pombo; Fahrettin Kelestimur; Carlos Dieguez; Felipe F Casanueva
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.925

View more
  4 in total

1.  The impact of weight loss on the 24-h profile of circulating peptide YY and its association with 24-h ghrelin in normal weight premenopausal women.

Authors:  Brenna R Hill; Mary Jane De Souza; David A Wagstaff; Nancy I Williams
Journal:  Peptides       Date:  2013-09-03       Impact factor: 3.750

Review 2.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

3.  Changes in appetite-regulating hormones following food intake are associated with changes in reported appetite and a measure of hedonic eating in girls and young women with anorexia nervosa.

Authors:  Christopher Mancuso; Alyssa Izquierdo; Meghan Slattery; Kendra R Becker; Franziska Plessow; Jennifer J Thomas; Kamryn T Eddy; Elizabeth A Lawson; Madhusmita Misra
Journal:  Psychoneuroendocrinology       Date:  2019-12-23       Impact factor: 4.905

4.  Effects of intensive training on menstrual function and certain serum hormones and peptides related to the female reproductive system.

Authors:  Geum Joon Cho; Sung Won Han; Jung-Ho Shin; Tak Kim
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.